Search research articles
Contact Us
Filters
Showing results (91-100 of 103) with videos related to
Page
of 11
Sort By:
The Laryngoscope
|
June 23, 2009
Fungal rhinosinusitis: a categorization and definitional schema addressing current controversies
Arunaloke Chakrabarti, David W Denning, Berrylin J Ferguson, et al.
The Journal of Urology
|
June 20, 2020
Five-Factor Prognostic Model for Survival of Post-Platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors
Guru Sonpavde, Juliane Manitz, Chen Gao, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery
|
January 20, 2019
Cerebellar mutism after posterior fossa tumor resection in children: a multicenter international retrospective study to determine possible modifiable factors
Bryan Renne, Julia Radic, Deepak Agrawal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 25, 2015
Survival, Durable Response, and Long-Term Safety in Patients With Previously Treated Advanced Renal Cell Carcinoma Receiving Nivolumab
David F McDermott, Charles G Drake, Mario Sznol, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 5, 2014
Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab
Suzanne L Topalian, Mario Sznol, David F McDermott, et al.
The New England Journal of Medicine
|
September 16, 2024
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer
Thomas Powles, James W F Catto, Matthew D Galsky, et al.
Cancer Discovery
|
July 7, 2021
Resistance to Durvalumab and Durvalumab plus Tremelimumab Is Associated with Functional <i>STK11</i> Mutations in Patients with Non-Small Cell Lung Cancer and Is Reversed by STAT3 Knockdown
Nabendu Pore, Song Wu, Nathan Standifer, et al.
The New England Journal of Medicine
|
June 4, 2013
Nivolumab plus ipilimumab in advanced melanoma
Jedd D Wolchok, Harriet Kluger, Margaret K Callahan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 7, 2023
Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
Suzanne L Topalian, Mario Sznol, David F McDermott, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology
|
January 9, 2019
Indian consensus on chronic constipation in adults: A joint position statement of the Indian Motility and Functional Diseases Association and the Indian Society of Gastroenterology
Uday C Ghoshal, Sanjeev Sachdeva, Nitesh Pratap, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 103) with videos related to
Sort By:
Page
of 11
The Laryngoscope
|
June 23, 2009
Fungal rhinosinusitis: a categorization and definitional schema addressing current controversies
Arunaloke Chakrabarti, David W Denning, Berrylin J Ferguson, et al.
The Journal of Urology
|
June 20, 2020
Five-Factor Prognostic Model for Survival of Post-Platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors
Guru Sonpavde, Juliane Manitz, Chen Gao, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery
|
January 20, 2019
Cerebellar mutism after posterior fossa tumor resection in children: a multicenter international retrospective study to determine possible modifiable factors
Bryan Renne, Julia Radic, Deepak Agrawal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 25, 2015
Survival, Durable Response, and Long-Term Safety in Patients With Previously Treated Advanced Renal Cell Carcinoma Receiving Nivolumab
David F McDermott, Charles G Drake, Mario Sznol, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 5, 2014
Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab
Suzanne L Topalian, Mario Sznol, David F McDermott, et al.
The New England Journal of Medicine
|
September 16, 2024
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer
Thomas Powles, James W F Catto, Matthew D Galsky, et al.
Cancer Discovery
|
July 7, 2021
Resistance to Durvalumab and Durvalumab plus Tremelimumab Is Associated with Functional <i>STK11</i> Mutations in Patients with Non-Small Cell Lung Cancer and Is Reversed by STAT3 Knockdown
Nabendu Pore, Song Wu, Nathan Standifer, et al.
The New England Journal of Medicine
|
June 4, 2013
Nivolumab plus ipilimumab in advanced melanoma
Jedd D Wolchok, Harriet Kluger, Margaret K Callahan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 7, 2023
Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
Suzanne L Topalian, Mario Sznol, David F McDermott, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology
|
January 9, 2019
Indian consensus on chronic constipation in adults: A joint position statement of the Indian Motility and Functional Diseases Association and the Indian Society of Gastroenterology
Uday C Ghoshal, Sanjeev Sachdeva, Nitesh Pratap, et al.
Page
of 11